We are live on
!
Find out more
Vanguard Global Advisers Portfolio holdings
AUM
$215B
This Fund
S&P 500
This Quarter
Est. Return
+22.32%
1 Year Est. Return
–
3 Year Est. Return
–
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$215B
AUM Growth
+$28.1B
(+15%)
Cap. Flow
+$1.96B
Cap. Flow
% of AUM
0.91%
Top 10 Holdings %
Top 10 Hldgs %
41.33%
Holding
3,754
New
71
Increased
744
Reduced
1,650
Closed
116
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Vanguard S&P 500 ETF
VOO
|
+$1.11B |
| 2 |
Vanguard Morningstar Total Stock Market ETF
VTI
|
+$688M |
| 3 |
Marvell Technology
MRVL
|
+$294M |
| 4 |
Vanguard FTSE Emerging Markets ETF
VWO
|
+$214M |
| 5 |
Royal Bank of Canada
RY
|
+$166M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
NVIDIA
NVDA
|
+$189M |
| 2 |
Honeywell
HON
|
+$157M |
| 3 |
Apple
AAPL
|
+$124M |
| 4 |
Microsoft
MSFT
|
+$89M |
| 5 |
Amazon
AMZN
|
+$62.1M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 25.83% |
| 2 | Financials | 11.43% |
| 3 | Communication Services | 6.64% |
| 4 | Consumer Discretionary | 6.57% |
| 5 | Industrials | 6.38% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1826
Absci
ABSI
$1.59B
| $866K | ﹤0.01% |
74,742
+17,687
| +31% | +$99.6K |
|
1827
Agios Pharmaceuticals
AGIO
$2.01B
| $865K | ﹤0.01% |
23,317
-35
| -0.1% | -$1.06K |
|
1828
Olin
OLN
$2.17B
| $864K | ﹤0.01% |
43,602
-1,578
| -3% | -$41.2K |
|
1829
FB Financial Corp
FBK
$3.07B
| $864K | ﹤0.01% |
15,613
| – | – |
|
|
MPT
1830
Medical Properties Trust
MPT
$2.42B
| $864K | ﹤0.01% |
186,952
-19,333
| -9% | -$95.8K |
|
1831
Summit Therapeutics
SMMT
$10.2B
| $861K | ﹤0.01% |
59,105
-2,031
| -3% | -$36K |
|
1832
Amylyx Pharmaceuticals
AMLX
$2.39B
| $859K | ﹤0.01% |
47,851
| – | – |
|
1833
Skyward Specialty Insurance
SKWD
$2.33B
| $857K | ﹤0.01% |
14,692
-3,075
| -17% | -$145K |
|
1834
WisdomTree
WT
$3.5B
| $854K | ﹤0.01% |
50,406
+3,947
| +8% | +$69.9K |
|
1835
Merchants Bancorp
MBIN
$2.51B
| $853K | ﹤0.01% |
17,050
+813
| +5% | +$38.6K |
|
1836
Shake Shack
SHAK
$3B
| $851K | ﹤0.01% |
15,193
-1,044
| -6% | -$78.6K |
|
|
ARR
1837
Armour Residential REIT
ARR
$2.33B
| $850K | ﹤0.01% |
48,736
+3,805
| +8% | +$65.5K |
|
1838
Oportun Financial
OPRT
$346M
| $850K | ﹤0.01% |
148,925
+21,437
| +17% | +$115K |
|
1839
Disc Medicine
IRON
$3.07B
| $848K | ﹤0.01% |
11,597
-919
| -7% | -$63.1K |
|
1840
Cooper-Standard Automotive
CPS
$491M
| $847K | ﹤0.01% |
31,296
-5,621
| -15% | -$166K |
|
|
BCAX
1841
Bicara Therapeutics
BCAX
$1.65B
| $845K | ﹤0.01% |
28,469
+15,733
| +124% | +$351K |
|
1842
NuScale Power
SMR
$3.77B
| $844K | ﹤0.01% |
84,140
+21,904
| +35% | +$247K |
|
1843
CBIZ
CBZ
$2.97B
| $843K | ﹤0.01% |
26,286
-42
| -0.2% | -$1.31K |
|
1844
Cedar Fair
FUN
$1.6B
| $841K | ﹤0.01% |
39,492
-2,007
| -5% | -$41K |
|
1845
Cohen & Steers
CNS
$4.29B
| $837K | ﹤0.01% |
10,987
+28
| +0.3% | +$1.98K |
|
|
AAMI
1846
Acadian Asset Management
AAMI
$3.3B
| $836K | ﹤0.01% |
11,686
+1,306
| +13% | +$91K |
|
1847
Vericel Corp
VCEL
$2.23B
| $833K | ﹤0.01% |
18,732
-1,172
| -6% | -$42.2K |
|
1848
Braze
BRZE
$3.15B
| $833K | ﹤0.01% |
38,421
-2,461
| -6% | -$54.8K |
|
1849
Clover Health Investments
CLOV
$2.27B
| $832K | ﹤0.01% |
158,697
-597
| -0.4% | -$2.03K |
|
1850
Howard Hughes
HHH
$3.98B
| $830K | ﹤0.01% |
11,614
-560
| -5% | -$36.4K |
|
Similar funds
Vanguard Global Advisers's Q2 2026 Portfolio in Review
As of Q2 2026, Vanguard Global Advisers held 3,754 positions worth $215B, up 15% from $187B the previous quarter. Its ten largest holdings account for 41% of the portfolio.
Trading was light in Q2 2026: portfolio turnover was 5%. Vanguard Global Advisers opened 71 new positions and exited 116, leaving the 3,754-position portfolio largely intact.
By sector, the portfolio is most concentrated in Technology at 26% of assets, up from 23% a quarter earlier, followed by Financials and Communication Services.
- Vanguard Global Advisers's largest Q2 2026 buy was Honeywell Aerospace: 682,434 shares worth $151M.
- Vanguard Global Advisers added most to Vanguard S&P 500 ETF in Q2 2026, an estimated $1.11B increase.
- Vanguard Global Advisers's biggest Q2 2026 reduction was NVIDIA, cutting an estimated $189M.
- Vanguard Global Advisers fully exited Coterra Energy in Q2 2026, selling an estimated $58.2M.
- Vanguard Global Advisers's ten largest holdings make up 41% of its $215B portfolio in Q2 2026.
- Vanguard Global Advisers opened 71 new positions and closed 116 in Q2 2026.
- Vanguard Global Advisers's portfolio value rose 15% quarter-over-quarter to $215B.
Based on Vanguard Global Advisers's 13F filing for Q2 2026, filed 13 Aug 2026.